Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.

Conclusions: Rosuvastatin calcium at 10 mg/day was effective in lowering total cholesterol, LDL cholesterol, non-HDL cholesterol and hs-CRP in hemodialysis patients.
PMID: 19229822 [PubMed - in process] (Source: Journal of Nephrology)